Medicare Enrolled

Dr. Timothy Carter, MD

Neurology · Melbourne, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1223 GATEWAY DR STE 2G, Melbourne, FL 32901
3217254500
In practice since 2005 (20 years)
NPI: 1154311652 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Carter from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carter? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Carter

Dr. Timothy Carter is a neurology in Melbourne, FL, with 20 years in practice. Based on federal Medicare data, Dr. Carter performed 17,102 Medicare services across 829 unique beneficiaries.

Between the years covered by Open Payments, Dr. Carter received a total of $8,526 from 54 pharmaceutical and/or device companies across 484 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Carter is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 6% volume in FL$ $8,526 industry payments

Medicare Practice Summary

Medicare Utilization ↗
17,102
Medicare services
Top 6% in FL for neurology
829
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~855 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit15,922$5$12
Needle measurement of electrical activity in arm or leg muscles, complete study331$73$193
Office visit, established patient (30-39 min)306$88$255
Office visit, established patient (20-29 min)206$59$180
Nerve conduction, 9-10 studies107$153$418
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle45$56$151
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face40$114$325
Nerve conduction, 5-6 studies27$80$265
Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, first extremity26$95$310
Nerve conduction, 13 or more studies26$208$571
Office visit, established patient, complex (40-54 min)23$123$358
Needle measurement of electrical activity in arm or leg muscles, limited study21$45$120
Nerve conduction, 11-12 studies11$166$490
New patient office visit (45-59 min)11$108$334
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$8,526
Total received (2018-2024)
Avg $1,218/year across 7 years
Top 30% in FL for neurology
54
Companies
484
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,358 (98.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$168 (2.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25
2023
$200
2022
$310
2021
$1,270
2020
$1,381
2019
$2,925
2018
$2,416

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$831
Intuitive Surgical, Inc.
$549
Teva Pharmaceuticals USA, Inc.
$459
Amgen Inc.
$410
GENZYME CORPORATION
$382
EMD Serono, Inc.
$359
Alexion Pharmaceuticals, Inc.
$336
Biogen, Inc.
$317
Supernus Pharmaceuticals, Inc.
$299
AbbVie Inc.
$269
UCB, Inc.
$262
Sunovion Pharmaceuticals Inc.
$257
Lundbeck LLC
$254
Avanir Pharmaceuticals, Inc.
$241
ACADIA Pharmaceuticals Inc
$223
Genentech USA, Inc.
$217
Allergan, Inc.
$204
Lilly USA, LLC
$203
Acorda Therapeutics, Inc
$168
Greenwich Biosciences, Inc.
$162
Ipsen Biopharmaceuticals, Inc
$144
Allergan Inc.
$141
Biohaven Pharmaceuticals, Inc.
$137
Eisai Inc.
$129
Kyowa Kirin, Inc.
$127
Merz North America, Inc.
$118
PFIZER INC.
$110
Adamas Pharmaceuticals, Inc.
$105
ABBVIE INC.
$96
Bayer HealthCare Pharmaceuticals Inc.
$90
EISAI INC.
$90
US WorldMeds, LLC
$82
Assertio Therapeutics, Inc.
$67
LivaNova USA, Inc.
$55
Takeda Pharmaceuticals U.S.A., Inc.
$54
Grifols USA, LLC
$51
Neurocrine Biosciences, Inc.
$50
AbbVie, Inc.
$48
Janssen Pharmaceuticals, Inc
$45
Upsher-Smith Laboratories LLC
$44
PORTOLA PHARMACEUTICALS, INC.
$44
Mallinckrodt Enterprises LLC
$39
Celgene Corporation
$38
Mallinckrodt LLC
$33
Neurelis, Inc.
$32
CSL Behring
$24
CATALYST PHARMACEUTICALS, INC.
$23
ASSERTIO THERAPEUTICS, Inc.
$19
MERZ NORTH AMERICA, INC.
$17
UPSHER-SMITH LABORATORIES LLC
$15
Mallinckrodt Hospital Products Inc.
$15
Merz Pharmaceuticals, LLC
$15
IDORSIA PHARMACEUTICALS US INC
$14
BOSTON SCIENTIFIC CORPORATION
$13
Top 3 companies account for 21.6% of total payments
Associated products mentioned in payments ›
ACTHAR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adempas · Aimovig · Austedo XR · BEVYXXA · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COPAXONE · Cambia · DUOPA · DYSPORT · Da Vinci Surgical System · Duopa · Dysport · EMGALITY · Epidiolex · Evrysdi · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GILENYA · GOCOVRI · Gamunex-C · Gralise · Hizentra · INBRIJA · INGREZZA · KESIMPTA · LATUDA · LEMTRADA · LYRICA · MAVENCLAD · MAYZENT · MYOBLOC · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · ONFI · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · QUVIVIQ · Rebif · SOLIRIS · SPINRAZA · Soliris · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · UBRELVY · VALTOCO · VNS Therapy · VYEPTI · Vimpat · XEOMIN · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $50 per 100 Medicare services performed
Looking for a neurology in Melbourne?
Compare neurologys in the Melbourne area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
30
Per 100K population
4.8
County median income
$75,817
Nearest hospital
HOLMES REGIONAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Carter is a mixed practice specialist, with above-average Medicare volume (top 6% in FL), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Carter experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Carter performed 15,922 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Carter receive payments from pharmaceutical companies?
Yes. Dr. Carter received a total of $8,526 from 54 companies across 484 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carter's costs compare to other neurologys in Melbourne?
Dr. Carter's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carter) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →